Answers are grounded in this paper and cite their sources.
PURPOSE: To investigate the interactions between microRNA-29 (miR-29), a negative regulator of extracellular matrix (ECM), and transforming growth factors (TGF)β-1 and TGFβ-2. METHODS: Changes in expression of the miR-29 family were analyzed by quantitative-PCR (Q-PCR) after treatment with TGFβ1 and TGFβ2 (1 ng/mL). TGFβ1 and TGFβ2 were evaluated at gene expression and protein levels by Q-PCR and ELISA, respectively, in human trabecular meshwork (HTM) cells transfected with miR-29b or scramble control. TGFβ1 promoter activity was analyzed using an adenovirus with the reporter SEAP. The effects of miR-29b and TGFβ2 on ECM gene expression were evaluated in cells transfected with miR-29b or scramble control and treated with TGFβ2, and the expression of ECM genes was analyzed by Q-PCR. RESULTS: TGFβ2 but not TGFβ1, downregulated the three members of the miR-29 family. Overexpression of miR-29b antagonized the effects of TGFβ2 on the expression of several ECM components. MiR-29b decreased the expression of TGFβ1 at the promoter, transcript, and protein levels but had only a minor effect on the expression of active TGFβ2. The inhibition of TGFβ1 by miR-29b was partially recovered after co-transfection with a plasmid-expressing bone morphogenetic protein 1. CONCLUSIONS: Results showed some level of crosstalk between TGFβs and miR-29. Specifically, the downregulation of miR-29 by TGFβ2 contributed to the induction of several ECM components by this cytokine in TM cells. This observation, together with the inhibitory effects of miR-29b on the expression of TGFβ1, suggests that the miR-29 family could play an important role in modulating TGFβs on the outflow pathway.
No takes yet. Share an insight, caveat, or question.
Luna et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: